What Is SHOWW Rx?
SHOWW Rx has done something sensible with its package design. Rather than selling a month of medication at a fixed dose and repeating it, its three-month packages map to the actual titration schedule — a published T1 package at $795, roughly $265 a month, running 2.5 mg for weeks one to four, 5 mg for weeks five to eight, and 7.5 mg for weeks nine to twelve.
That structure reflects how GLP-1 treatment actually works. Nobody stays at 2.5 mg, and a package priced around the escalation you will genuinely undertake is more honest than a low entry rate that expires the moment you titrate.
Monthly pricing is published clearly too. SHOWW's own FAQ puts compounded semaglutide at typically $297 a month and compounded tirzepatide from $397, while its Trustpilot presence advertises semaglutide starting at $197 and tirzepatide at $297 — up to 75% less than brand-name products, with no hidden fees.
The range between those figures suggests dose and package both matter. SHOWW is not the cheapest platform in this review set, but the titration-aware packaging is a genuine design advantage and the pricing is stated openly rather than buried.
How SHOWW Rx Works
- 1
Online medical intake
A health questionnaire covering weight history, conditions, and medications, reviewed by a licensed clinician for eligibility.
- 2
Clinician review and prescription
A licensed provider evaluates you and prescribes compounded semaglutide or tirzepatide with an appropriate starting dose.
- 3
Choose monthly or a titration package
Monthly billing sits at roughly $297 semaglutide and $397 tirzepatide. Three-month packages such as the T1 at $795 bundle the escalation schedule at a lower effective rate.
- 4
Titration built into the package
The T1 package covers 2.5 mg for weeks 1–4, 5 mg for weeks 5–8, and 7.5 mg for weeks 9–12, so escalation is planned rather than repriced.
- 5
Ongoing supply after the package
Once the initial titration package completes, confirm what your maintenance rate becomes before assuming the package rate continues.
Medications & Pricing
What SHOWW Rx offers and the prices advertised at the time of this review.
| Medication | Format | Advertised price | Notes |
|---|---|---|---|
| Compounded semaglutide | Weekly injection | $197–$297/mo | Entry rate advertised at $197; FAQ describes $297 typical |
| Compounded tirzepatide | Weekly injection | $297–$397/mo | Entry $297; FAQ describes $397 as the usual range |
| T1 three-month package | 12 weeks, titrating | $795 total, about $265/mo | 2.5 mg weeks 1–4, 5 mg weeks 5–8, 7.5 mg weeks 9–12 |
| Hidden fees | None advertised | $0 | Platform states no hidden fees, fair and honest pricing |
SHOWW publishes both entry and typical rates, which differ meaningfully — $197 versus $297 for semaglutide, $297 versus $397 for tirzepatide. Budget from the higher figure and ask what your rate becomes once the titration package completes.Pricing changes frequently across the GLP-1 market — always confirm the current cost on the provider's own site before enrolling.
Key Features
Packages built around real titration
The T1 package covers a full twelve-week escalation from 2.5 mg to 7.5 mg, matching how treatment actually progresses rather than selling one dose repeatedly.
Published dose schedules
SHOWW states exactly which dose runs in which weeks, which is more clinical transparency than most platforms provide about what you are buying.
Meaningful package savings
About $265 a month within the T1 package against roughly $397 monthly for tirzepatide is a substantial reduction for committing twelve weeks.
No hidden fees stated
The platform explicitly claims fair and honest pricing without hidden charges, which its published rates broadly support.
Both molecules available
Semaglutide and tirzepatide are both offered, so a clinical switch is possible without changing platforms.
Public review presence
A Trustpilot presence provides an independent signal about real patient experiences rather than curated testimonials.
SHOWW Rx and Food Noise
The titration-package design is genuinely well suited to food noise, and the reason is worth stating. Relief arrives at a threshold dose, and for tirzepatide that threshold is frequently around the 7.5 mg mark — which is exactly where the T1 package ends. Buying the escalation as a planned twelve-week course rather than a series of repricing decisions makes it far more likely you actually get there.
Contrast that with the dominant market pattern: a cheap first month at the lowest dose, then a price increase at every step, and a patient who stalls at 5 mg because the next increase costs more. SHOWW's structure removes that decision point entirely for the first twelve weeks.
The question to resolve is what happens afterwards. Once the package completes and you move to maintenance, your rate becomes the monthly figure — around $397 for tirzepatide by the FAQ's own description. That is not cheap, and it arrives at the point where you most want to continue.
There is no coaching or behavioural support, so the eating patterns that persist after appetite change are yours to work on separately.
If the constant mental chatter about food is your main reason for seeking treatment, read our primer on what food noise actually is and how GLP-1 medications quiet it.
What SHOWW Rx Patients Say
Composite patient accounts illustrating experiences commonly reported by people using SHOWW Rx for GLP-1 medication management. Names are illustrative and individual results vary.
Bernadette C.
Compounded tirzepatide via SHOWW Rx · 6 months
The T1 package was the smartest thing I found. Twelve weeks covering 2.5 through 7.5 mg at one price meant I never had to decide whether an increase was worth the money — it was already paid for. My food noise went completely quiet at the 7.5 mg step, which is exactly where the package ends. Good design.
Aiden R.
Compounded semaglutide via SHOWW Rx · 5 months
Prices are published clearly and I've had no surprise charges, which after two other platforms is worth something. My appetite chatter is much reduced. The entry rate and the typical rate are different numbers though — I'd budget from the higher one rather than the marketing figure.
Priyanka M.
Compounded tirzepatide via SHOWW Rx · 7 months
Great for the first twelve weeks, more expensive afterwards. The package rate worked out around $265 a month and my maintenance rate is closer to $397. That's disclosed but it's a real jump right when you want to keep going. Food noise substantially better and I've stayed on.
Desmond K.
Compounded semaglutide via SHOWW Rx · 4 months
Knowing exactly which dose I'd be on in which weeks before I paid was genuinely reassuring — most platforms are vague about it. Delivery has been reliable and the medication is working. It's a supply service with no coaching, which the price broadly reflects.
Lorraine V.
Compounded tirzepatide via SHOWW Rx · 8 months
Not the cheapest but the structure is better thought through than most. Being carried through the whole titration in one purchase meant I reached an effective dose instead of stalling. My food noise is much quieter than it was and I've lost 38 lbs.
Who SHOWW Rx Is Right For
A good fit if you
- ✓Are starting treatment and want the titration period priced as one course
- ✓Value knowing exactly which dose runs in which weeks
- ✓Want to avoid repricing decisions at every escalation step
- ✓Prefer published pricing over quote funnels
- ✓Are self-directed and do not need coaching
Look elsewhere if you
- →Want the lowest monthly rate in the market
- →Will be on a high maintenance dose and want cheap ongoing pricing
- →Want coaching or behavioural support
- →Want brand-name FDA-approved medication
- →Need month-to-month flexibility at the package rate
Pros & Cons
Pros
- +Three-month packages structured around real titration schedules
- +Published dose-by-week breakdown before you buy
- +About $265 a month within the T1 package
- +No hidden fees stated and broadly supported by published rates
- +Both semaglutide and tirzepatide available
- +Public Trustpilot presence for independent signal
Cons
- -Entry and typical rates differ substantially
- -Maintenance pricing after the package is considerably higher
- -Not the cheapest platform in this category
- -No coaching or behavioural support
- -Compounded medications are not FDA-approved
Frequently Asked Questions
How much does SHOWW Rx cost?+
Its FAQ describes compounded semaglutide at typically $297 a month and tirzepatide from $397, while entry rates are advertised at $197 and $297 respectively. The T1 three-month package is $795, roughly $265 a month, covering a full titration from 2.5 mg to 7.5 mg.
What is the T1 package?+
A twelve-week course priced at $795 that runs 2.5 mg for weeks one to four, 5 mg for weeks five to eight, and 7.5 mg for weeks nine to twelve. It prices the escalation you will actually undertake rather than selling one dose repeatedly.
Why does titration-based packaging matter?+
Because food noise relief arrives at a threshold dose most patients only reach after several increases, and on tiered platforms each increase costs more. A package covering the full escalation removes that repricing decision and makes reaching an effective dose far more likely.
What happens after the package ends?+
You move to monthly pricing, described in SHOWW's FAQ as around $297 for semaglutide and $397 for tirzepatide. That is a meaningful step up arriving at the point you most want to continue, so budget for it before starting.
Are there hidden fees?+
SHOWW states there are none, advertising fair and honest pricing, and its published rates broadly support that. Confirm at checkout what is included in your specific package.
Are the medications FDA-approved?+
No. SHOWW Rx supplies compounded semaglutide and tirzepatide, which are not FDA-approved products.
Our Verdict
SHOWW Rx has thought harder about package design than most of this market, and it shows. Pricing a twelve-week course that runs 2.5 mg through 7.5 mg — with the dose schedule published before you buy — matches how GLP-1 treatment actually progresses, and it removes the repricing decision at every escalation step that causes so many patients to stall below an effective dose. For tirzepatide patients in particular, the package ends right around where food noise typically goes quiet, which is good design rather than coincidence. The weakness is what comes next: maintenance pricing near $397 arrives just as you want to keep going, and the advertised entry rates are well below the typical ones. Budget from the higher figures and take the package for the titration it buys you.
Visit SHOWW RxHow does SHOWW Rx compare?
We have reviewed 167 GLP-1 providers. See where this one lands against the rest:
Continue Reading
This review is editorial content, not medical advice. Food Noise Stop is not affiliated with SHOWW Rx. GLP-1 medications require a prescription and clinical supervision — talk to a licensed clinician about whether treatment is appropriate for you. See our medical disclaimer and affiliate disclosure.